Download the full report (116 p.) - KCE
Download the full report (116 p.) - KCE
Download the full report (116 p.) - KCE
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>KCE</strong> Reports 82 Multislice CT in Coronary Heart Disease 13<br />
to an acute coronary event. 28 Therefore, and owing to <strong>the</strong> high cost and <strong>the</strong> potential<br />
complications, routine use of CCA without prior noninvasive testing is not advisable. 14 If<br />
noninvasive functional testing is not feasable, functional testing can be done invasively by<br />
means of pressure-derived fractional flow reserve (FFR) measurements. 28 This can be<br />
done immediately after <strong>the</strong> imaging procedure by intravascular pressure recordings<br />
through <strong>the</strong> ca<strong>the</strong>ter that was used for contrast injection into <strong>the</strong> coronary arteries.<br />
CCA is an invasive procedure, carrying a certain risk that is related to radiation<br />
exposure, <strong>the</strong> direct access of <strong>the</strong> heart and vascular structures and <strong>the</strong> administration<br />
of contrast media. The most serious complications of CCA are death (0.1–0.2%), nonfatal<br />
MI (0.1%) and cerebrovascular accidents (0.1%). 24 Allergic contrast reactions and<br />
renal failure may result from contrast medium exposure. Bleeding from vascular access<br />
sites (groin) may result in substantial bleeding, requiring transfusion and sometimes,<br />
vascular surgery is needed to repair <strong>the</strong> damage to <strong>the</strong> femoral artery. In addition,<br />
patients are temporarily subjected to bed rest, often staying overnight in hospital and<br />
delayed in returning to work. The composite rate of major complications associated<br />
with routine diagnostic ca<strong>the</strong>terisation is between 1 and 2%. 4<br />
It has been a matter of concern that in some series up to 50% of CCAs reveal normal<br />
coronary arteries or do not lead to revascularisation. Consequently, in order to try to<br />
avoid <strong>the</strong>se “unnecessary” invasive procedures, <strong>the</strong>re has been increasing interest in<br />
noninvasive imaging techniques.<br />
Some of <strong>the</strong> inconveniences and complications of CCA, related to <strong>the</strong> intravascular<br />
access by means of a ca<strong>the</strong>ter, can be avoided by using CT scanning for coronary artery<br />
imaging, which is <strong>the</strong> topic of fur<strong>the</strong>r discussion in this <strong>report</strong>.<br />
Key points<br />
• Conventional coronary angiography (CCA) is considered <strong>the</strong> gold<br />
standard for assessing coronary anatomy.<br />
• It is however not a reliable indicator of <strong>the</strong> functional significance of<br />
a coronary stenosis indicating that <strong>the</strong> results of a functional test<br />
are necessary before proceeding to revascularisation.<br />
• Ano<strong>the</strong>r limitation is that it carries risks related to radiation<br />
exposure, <strong>the</strong> direct access of <strong>the</strong> heart and <strong>the</strong> administration of<br />
contrast media. The most serious complications of CCA are death<br />
(0.1–0.2%), non-fatal MI (0.1%) and cerebrovascular accidents (0.1%)<br />
2.3 DIAGNOSIS OF CAD IN ACUTE CONDITIONS<br />
Based on history taking and an electrocardiogram (ECG), a qualified physician must be<br />
able to assign a diagnosis of “ACS” or “highly unlikely ACS” within 10 minutes after <strong>the</strong><br />
first medical contact. 29 In patients with an atypical history, negative clinical findings and a<br />
non-evolutive ECG, serum biomarkers are useful in diagnosing <strong>the</strong> cardiac origin of <strong>the</strong><br />
patient’s complaints and in assessing prognosis.<br />
Troponins are <strong>the</strong> best biomarkers to predict short and long-term outcome (beyond 1<br />
year) with respect to MI and death. 29 Even minor myocardial damage can be excluded<br />
based on two repetitive troponin measurements, one on admission and a second<br />
between 6 and12 hours later. Patients fulfilling <strong>the</strong> following criteria may be considered<br />
at low risk for future events and should not be submitted to early invasive evaluation:<br />
no recurrence of chest pain, no heart failure, no abnormalities on <strong>the</strong> first and a<br />
subsequent ECG and no elevation of troponins (at arrival and after 6 to12 hours).<br />
Patients who cannot be excluded by <strong>the</strong> above criteria should go on to cardiac<br />
ca<strong>the</strong>terisation.